Showing 15 posts of 28 posts found.

Spanner in the works for Sputnik V as missing data reported

July 13, 2021
Manufacturing and Production COVID-19, EMA, Russia, Vaccine

Developers of Russia’s Sputnik V COVID-19 vaccine have repeatedly failed to present data to regulators, Reuters has reported. Five sources …

RDIF & Stelis Biopharma to supply 200 million doses of the Sputnik V vaccine

March 19, 2021
Medical Communications COVID-19, Russia, Vaccine

The Russian Direct Investment Fund (RDIF) and Stelis Biopharma have today announced a partnership which aims to produce and supply …


First interim Phase 3 data shows promise for Russia’s Sputnik V COVID-19 vaccine

November 11, 2020
Research and Development COVID-19, Russia, Sputnik V, Vaccine

The first interim Phase 3 data for Russia’s Sputnik V COVID-19 vaccine have been released by the Gamaleya Research Center …


Russia is spreading lies about COVID-19 vaccines, alleges UK Chief of Defence Staff

October 1, 2020
Research and Development Hackers, Russia, Russians, coronavirus vaccine

Russia is sowing disinformation about COVID-19 vaccines to undermine inoculation efforts in Western aligned countries, according to a top UK …


One in seven Russian COVID-19 vaccine recipients display side-effects, says Health Minister

September 18, 2020
Medical Communications, Research and Development COVID-19, Russia, Sputnik V, Vaccine

Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …


India signs deal for 100m doses of Russia’s Sputnik V COVID-19 vaccine

September 16, 2020
Manufacturing and Production, Research and Development COVID-19, India, Russia, Vaccine

Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …


Russia claims it will start mass immunisation with a COVID-19 vaccine from October

August 4, 2020
Manufacturing and Production Russia, Vaccine, putin

The Russian government is claiming it will start production of a viable coronavirus vaccine candidate next month and begin the …


Russia to begin administering anti-viral COVID-19 drug next week

June 1, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Russia, coronavirus, pandemic, virus

Russia will start its roll out of the anti-viral drug Avifavir (favipiravir) to COVID-19 patients next week, according to the …


Venezuela relaunch pharmaceutical industry with Chinese and Russian backing

March 21, 2019
Manufacturing and Production China, Maduro, Russia, USA, Venezuela, pharma

President Maduro has pledged to relaunch Venezuela’s pharmaceutical industry, as part of an effort to address shortages of medicines in …


Russian trolls spread vaccine misinformation on Twitter

August 28, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing Russia, misinformation, public health, study, vaccines

Twitter bots and Russian trolls post content about vaccination at significantly higher rates than normal users, a new study has …


Sun Pharma makes strategic Russian firm acquisition

November 23, 2016
Research and Development, Sales and Marketing Biosintez, Russia, Sun Pharma

Sun Pharmaceutical, India’s largest pharmaceutical company, has acquired Russian pharmaceutical company JSC Biosintez in a total deal of $60 million. …

Novo image

Novo Nordisk opens insulin plant in Russia

April 10, 2015
Manufacturing and Production, Sales and Marketing Novo Nordisk, Russia, diabetes, flexpen, insulin, kaluga, penfill

Denmark’s Novo Nordisk has opened a new manufacturing facility in Russia to produce more of its diabetes offerings in the …

Takeda HQ image

Takeda opens Russian manufacturing facility

September 11, 2012
Manufacturing and Production Actovegin, Nycomed, Russia, Takeda

Takeda Pharmaceutical has officially opened its new manufacturing facility in Yaroslavl, Russia, and expects it to be operating at full …

Eisai to enter Russia with epilepsy launch

June 27, 2012
Sales and Marketing Eisai, Russia, Zonegran, emerging markets, epilepsy

Eisai is to enter the Russian market for the first time with the launch of epilepsy drug Zonegran. Entry into the …

Angel Bio plans joint venture with Russian drugmaker

October 18, 2011
Manufacturing and Production Angel Biotechnology, Materia Medica, Russia, biologics

UK contract manufacturing organisation Angel Biotechnology has agreed to set up a joint venture with Russian counterpart Materia Medica Holding …

Latest content